https://www.aafp.org/pubs/afp/issues/2024/0600/steps-respiratory-syncytial-virus-infection.html
RSVpreF (Abrysvo) is a respiratory syncytial virus (RSV) vaccine. It induces antibodies to the viral surface protein (protein F) that attaches the virus to...
abrysvonirsevimabalipbeyfortusprevention
https://www.aha.org/news/headline/2025-11-20-report-finds-nirsevimab-80-effective-preventing-rsv-associated-icu-admissions
Nirsevimab was found to be 80% effective at preventing respiratory syncytial virus-associated intensive care unit admissions during the 2024-2025 RSV season,...
reportfindsnirsevimabeffectivepreventing